Induction of cyclin D1 by arsenite and UVB-irradiation in human keratinocytes

Journal of Health Care for the Poor and Underserved

Volumn 22, Issue 4 SUPPL., 2011, Pages 110-121

  Liu, Suqing ^a   Gonzalez, Julian ^a   Hwang, Bor Jang ^a   Steinberg, Mark L ^a  

^a CITY COLLEGE OF NEW YORK   (United States)

Author keywords

Arsenic; Cyclin D1; Microarray; Promoter methylation

Indexed keywords

EID: 84855288671     PISSN: 10492089     EISSN: 15486869     Source Type: Journal    
DOI: 10.1353/hpu.2011.0158     Document Type: Article

References (41)

1. Chen CJ, Wang CJ. Ecological correlation between arsenic level in well water and ageadjusted mortality from malignant neoplasms. Cancer Res. 1990 Sep. 1; 50(17):5470-4.
2. Engel RR, Hopenhayn-Rich C, Receveur O, et al. Vascular effects of chronic arsenic exposure: a review. Epidem Rev. 1994;16(2):184-209.
3. Chen C, Hsueh YM, Lai MS, et al. Increased prevalence of hypertension and longterm arsenic exposure. Hypertension. 1995 Jan; 25(1):53-60.
4. International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risk of chemicals to man, some metals and metallic compounds (Vol. 23). Lyon, France: International Agency for Research on Cancer, 1980.
5. National Research Council. Arsenic in drinking water. Washington, DC: National Academy Press, 2000.
6. Agency for Toxic Substances and Disease Registry. Toxicological profile for arsenic. Atlanta, GA: U. S. Department of Health and Human Services, 1992.
7. Cöl M, Cöl C, Soran A, et al. Arsenic-related Bowens disease, palmar keratosis, and skin cancer. Environ Health Perspect. 1999;107(8):687-9. (Pubitemid 29412783)
8. Hsueh Y, Cheng GS, Wu MM, et al. Multiple risk factors associated with arsenicinduced skin cancer: effects of chronic liver disease and malnutritional status. Brit J Cancer. 1995 Jan; 71(1):109-14.
9. Tsuda T, Babazono A, Yamamoto E, et al. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol. 1995 Feb. 1; 141(3):198-209.
10. Tondel M, Rahman M, Magnuson A, et al. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. Environ Health Persp. 1999 Sep; 107(9):727-9. (Pubitemid 29478883)
11. Pershagen G. The carcinogenicity of arsenic. Environ Health Perspect. 1981 Aug; 40:93-100. (Pubitemid 12231149)
12. Chiou HY, Hsueh YM, Liaw KF, et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 1995 Mar. 15; 55(6):1296-300.
13. Borzsonyi M, Bereczky A, Rudnai P, et al. Epidemiological studies on human subjects exposed to arsenic in drinking water in southeast Hungary. Arch Toxicol. 1992;66(1):77-8.
14. Bates MN, Smith AH, Cantor KP. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol. 1995;41(6):523-30.
15. Jarup L, Pershagen G. Arsenic exposure, smoking, and lung cancer in smelter workers-a case-control study. Am J Epidemiol. 1991 Sep. 15; 134(6):545-51.
16. Enterline PR, Day R, Marsh GM. Cancers related to exposure to arsenic at a copper smelter. Occupat Environ Med. 1995 Jan; 52(1):28-32.
17. Dong JT, Zhou CN, Luo XM. Induction of preneoplastic lesions by sodium arsenite in human fetal respiratory epithelia in organ culture. Environ Res. 1995 Jan; 68(1):39-43.
18. Pellizzari ED, Perritt RL, Clayton CA. National human exposure assessment survey (NHEXAS): exploratory survey of exposure among population subgroups in EPA Region V. J Expo Anal Environ Epidemiol. 1999;9(1):49-55. (Pubitemid 29502607)
19. Bradford PT. Skin cancer in skin of color. Dermatol Nurs. 2009;21(4):170-7.
20. Chen H, Liu J, Zhao CQ, et al. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol Appl Pharmacol. 2001;175(3):260-8. (Pubitemid 32917750)
21. Hernandez-Zavala A, Cordova E, Del Razo LM, et al. Effects of arsenite on cell cycle progression in a human bladder cancer cell line. Toxicology. 2005;207(1):49-57. (Pubitemid 39601685)
22. Simeonova PP, Wang S, Toriuma W, et al. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res. 2000;60(13):3445-53. (Pubitemid 30482163)
23. Suriano G, Mulholland D, de Wever O, et al. The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene. 2003;22(36):5716-9. (Pubitemid 37102710)
24. Suriano G, Yew S, Ferreira P, et al. Characterization of a recurrent germ line mutation of the E-Cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res. 2005;11(15):5401-9. (Pubitemid 41060814)
25. Lynch HT, Grady W, Suriano G, et al. Gastric cancer: new genetic developments. J Surg Oncol. 2005;90(3):114-33. (Pubitemid 40741172)
26. Kim HS, Hong EK, Park SY, et al. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach. Anticancer Res. 2003;23(3c):2863-8. (Pubitemid 36969824)
27. Cheng XX, Wang ZC, Chen XY, et al. Frequent loss of membranous E-cadherin in gastric cancers: a cross-talk with Wnt in determining the fate of beta-catenin. Clin Exp Metastasis. 2005;22(1):85-93.
28. Rass K, Reichrath J. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008;624:162-78.
29. De Fabo EC, Noonan FP, Fears T, et al. Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Res. 2004;64:6372-6. (Pubitemid 39297887)
30. Kim AL, Athar M, Bickers DR, et al. Stage-specific alterations of cyclin expression during UVB-induced murine skin tumor development. Photochem Photobiol. 2002;75(1):58-67.
31. Burns FJ, Uddin AN, Wu F, et al. Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study. Env Health Perspect. 2004 Apr; 112(5):599-603. (Pubitemid 38500051)
32. Hwang BJ, Utti C, Steinberg M. Induction of cyclin D1 by submicromolar concentrations of arsenite in human epidermal keratinocytes. Toxicol Appl Pharmacol. 2006 Dec. 1; 217(2):161-7. Epub 2006 Aug. 11. (Pubitemid 44711967)
33. Fang J, Pierre Z, Liu S, et al. Novel mitochondrial deletions in human epithelial cells irradiated with an FS20 ultraviolet light source in vitro. J Photochem Photobiol. 2006 Dec. 15; 184(3):340-6.
34. Li X, Deng W, Nail CD, et al. Snail induction is an early response to Glil that determines the efficiency of epithelial transformation. Oncogene. 2006;99(4):609-21. (Pubitemid 43164471)
35. Adolphe C, Hetherington R, Ellis T, et al. Patched 1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res. 2006;99(5):2081-8.
36. Udensi UK, Cohly HH, Graham-Evans BE, et al. Aberrantly expressed genes in HaCaT keratinocytes chronically exposed to arsenic trioxide. Biomarker Insights. 2011 Feb. 8; 6:7-16.
37. Snow ET, Sykor P, Durham TR, et al. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk? Toxicol Appl Pharmacol. 2005 Sep. 1;207(2 Suppl):557-64.
38. Watanabe Y, Maekawa M. Methylation of DNA in cancer. Adv Clin Chem. 2010;52:145-67.
39. Ikehata H, Ono T. Significance of CpG methylation for solar UV-induced mutagenesis and carcinogenesis in skin. Photochem Photobiol. 2007;83(1):196-204. (Pubitemid 46697240)
40. van Doom R, Gruis NA, Willemze R, et al. Aberrant DNA methylation in cutaneous malignancies. Semin Oncol. 2005;32(5):479-87. (Pubitemid 41396425)
41. Nandakumar V, Vaid M, Tollefsbol TO, et al. Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice. Carcinogenesis. 2010;32(4):597-604.